The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center

Abstract

Background and study aims The COVID-19 pandemic is having a major clinical and also organizational impact on national health care systems, particularly in high-volume hospitals that are utilized for several essential clinical needs. We aimed to analyze the short-term impact of the SARS-CoV-2 pandemic on management of endoscopic procedures in patients with inflammatory bowel disease (IBD).

Patients and methods This was an observational prospective study exploring major clinical and organizational changes in endoscopic management at the IBD Center – CEMAD of the Fondazione Policlinico Gemelli IRCCS, Rome, Italy since the beginning of SARS-CoV-2 pandemic.

Results Our IBD Unit, with up to 1,500 IBD patients receiving biotechnological or experimental therapy, represents a high-volume Italian and European IBD center. Since the beginning of the outbreak, our hospital has been extremely impacted by care related to COVID-19 cases, with a consequent need to dramatically reorganize management of endoscopic procedures for IBD.

Conclusions Outbreak restrictions have significantly impacted the volume of endoscopic activities for IBD. Specific strategies have been designed to guarantee a high level of safety for both patients with IBD and healthcare personnel dedicated to their treatment.

Publication History

Received: 22 April 2020

Accepted: 05 May 2020

Article published online:
23 June 2020

• References

• 1 Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res 2011; 81: 85-164
• 2 World Health Organization. Pneumonia of unknown cause – China. https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/
• 3 World Health Organization. Coronavirus disease (COVID-2019) situation report-72. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200401-sitrep-72-covid-19.pdf?sfvrsn=3dd8971b_2
• 4 Verity R, Okell LC, Dorigatti I. et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 2020; DOI: 10.1016/S1473-3099(20)30243-7.
• 5 Wang C, Horby PW, Hayden FG. et al. A novel coronavirus outbreak of global health concern. Lancet 2020; 395: 470-473
• 6 Zhu N, Zhang D, Wang W. et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382: 727-733
• 7 Bamias G, Corridoni D, Pizarro TT. et al. New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. Cytokine 2012; 59: 451-459
• 8 Fiorino G, Allocca M, Furfaro F. et al. Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience. J Crohn Colitis 2020; DOI: 10.1093/ecco-jcc/jjaa058.
• 9 Mao R, Liang J, Shen J. et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol 2020; DOI: 10.1016/S2468-1253(20)30076-5.
• 10 ECCO. 1st Interview COVID-19 ECCO Taskforce, published March 13, 2020.
• 11 Wolfel R, Corman VM, Guggemos W. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020; DOI: 10.1038/s41586-020-2196-x.
• 12 Xiao F, Tang M, Zheng X. et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 2020; DOI: 10.1053/j.gastro.2020.02.055.
• 13 Gu J, Han B, Wang J. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gastroenterology 2020; DOI: 10.1053/j.gastro.2020.02.054.
• 14 World Health Organization. Q&A on Coronaviruses [COVID-19].
• 15 Dulai PS, Singh S, Ohno-Machado L. et al. Population health management for inflammatory bowel disease. Gastroenterology 2018; 154: 37-45
• 16 Fiorino G, Lytras T, Younge L. et al. Quality of care standards in inflammatory bowel diseases: a European Crohnʼs and Colitis Organisation (ECCO) position paper. J Crohn Colitis 2020; DOI: 10.1093/ecco-jcc/jjaa023.
• 17 Repici A, Maselli R, Colombo M. et al. Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Gastrointest Endosc 2020; DOI: 10.1016/j.gie.2020.03.019.
• 18 Tang JW, Li Y, Eames I. et al. Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises. J Hosp Infect 2006; 64: 100-114
• 19 Wong TW, Lee CK, Tam W. et al. Cluster of SARS among medical students exposed to single patient, Hong Kong. Emerg Infect Dis 2004; 10: 269-276
• 20 Rahier JF, Papay P, Salleron J. et al. Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series. Aliment Pharmacol Therap 2011; 33: 499-500